Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alport syndrome
Alport syndrome
Calliditas starts Phase II trial for rare kidney disease therapy
Clinical Trials Arena
Thu, 11/30/23 - 10:04 am
Calliditas Therapeutics
clinical trials
Alport syndrome
kidney disease
setanaxib
FDA rejects Reata Pharma chronic kidney disease drug; new trial needed
MedCity News
Mon, 02/28/22 - 09:15 am
Reata Pharmaceuticals
Bardoxolone
Alport syndrome
kidney disease
FDA
FDA adcomm votes unanimously against Reata's potential Alport syndrome treatment
Endpoints
Wed, 12/8/21 - 11:41 pm
FDA
Reata Pharmaceuticals
Alport syndrome
Reata's bardoxolone offers promise in patients with rare kidney disorder
Endpoints
Tue, 11/12/19 - 10:22 am
Reata Pharmaceuticals
Bardoxolone
chronic kidney disease
Alport syndrome